Germany: BMEL extends the exemption for vaccines against bluetongue disease

Published 2024년 11월 22일

Tridge summary

The article outlines the extension of an emergency ordinance by the BMEL, allowing the use of three vaccines to protect livestock from bluetongue disease (BTV-3) until a EU-approved vaccine is available. This extension, highlighted by Federal Minister Cem Özdemir, aims to mitigate the severe economic losses and fatalities in cattle, goats, and sheep caused by this virus. The vaccination is crucial to ensure the health and interest of livestock farmers, with the new ordinance enabling the continuous use of these vaccines beyond their initial six-month period.
Disclaimer:The above summary was generated by Tridge's proprietary AI model for informational purposes.

Original content

Federal Minister Cem Özdemir explains: "We must continue to offer our livestock farmers every opportunity to protect their cattle, sheep and goats from the serious consequences of bluetongue disease. The best way to do this is to vaccinate them in good time. We are therefore naturally extending the exemption for the three tailor-made vaccines. The health of your cattle, sheep and goats is also in the livestock farmers' own interest. So my appeal is: vaccinate your animals before the next midge season begins in spring." Bluetongue disease is a virus-related disease that is transmitted by a type of mosquito (midges). The current serotype 3 (BTV-3) causes severe cases, particularly in cattle, goats and sheep, which can also be fatal, especially in the latter two. This also often has serious economic consequences for livestock farmers. There is currently no EU-approved vaccine against this serotype. In June, the BMEL therefore issued an emergency ordinance permitting the immediate use ...
Source: Bmel

Would you like more in-depth insights?

Gain access to detailed market analysis tailored to your business needs.
By clicking “Accept Cookies,” I agree to provide cookies for statistical and personalized preference purposes. To learn more about our cookies, please read our Privacy Policy.